Characterization of these targets will not only reveal the cellular pathways on which Acer acts in Drosophila but may also reveal novel roles for mammalian ACE beyond its canonical role in RAS and lead to the development of additional therapies for AD. Here, ACE is linked to Alzheimer disease.